Business Overview
Earkart Limited is an integrated hearing healthcare platform offering diagnostics, hearing aids, and technology-enabled hearing solutions across India. The company leverages government contracts and an expanding Shop-in-Shop network, driving social impact with its proprietary OMNI Audiometer.
Financial Performance (₹ in Lakhs except EPS)
Full Year FY26 Results:
- Revenue from Operations: ₹5,403.53 (25.35% YoY increase from FY25's ₹4,310.62)
- Other Income: ₹10.65 (23.98% YoY increase)
- Total Income: ₹5,414.18
- Total Expenditure: ₹4,568.38 (37.01% YoY increase)
- EBITDA: ₹845.80 (14.12% YoY decrease from ₹984.86)
- EBITDA Margin: 15.65% (down from 22.85% in FY25)
- Depreciation: ₹66.03 (55.62% YoY increase)
- EBIT: ₹779.77 (17.26% YoY decrease)
- Interest: ₹54.21 (32.67% YoY increase)
- Profit Before Tax: ₹725.56 (19.52% YoY decrease)
- Tax: ₹232.33 (8.87% YoY increase)
- PAT: ₹493.23 (28.33% YoY decrease from ₹688.17)
- PAT Margin: 9.13% (down from 15.96% in FY25)
- EPS: ₹3.99 (39.45% YoY decrease from ₹6.59)
Half-Yearly Performance FY26:
- H2FY26 Revenue: ₹3,174.96 (42.47% increase over H1FY26's ₹2,228.57)
- H2FY26 PAT: ₹307.9 (66.14% increase over H1FY26's ₹185.33)
- H2FY26 EPS: ₹2.49 (84.44% increase over H1FY26's ₹1.35)
Revenue Geographic Distribution (FY26)
- Uttar Pradesh: ₹4,132.13 (76.47% of total revenue)
- Delhi: ₹462.97 (8.57%)
- Gujarat: ₹315.68 (5.84%)
- Haryana: ₹162.40 (3.01%)
- Madhya Pradesh: ₹77.86 (1.44%)
- Maharashtra: ₹77.76 (1.44%)
- Others: ₹174.74 (3.23%)
Business Model Segments
- Private Business: Sales through retailers, wholesalers, and direct customer engagement
- Government Business (B2G): Strong presence on Government e-Marketplace (GeM) portal and association with ALIMCO
- Service Revenue: Audiometry diagnostic tests, conversion charges, franchise fees, and consultancy services
- Shop-in-Shop (SIS) Model: 82 SIS clinics across ENT and optical centres in Tier 2 and 3 cities
Product Portfolio
- Brands: EQFY, Fame, Radius, Tiny
- Product Types: Behind-the-Ear (BTE) and Receiver-in-Canal (RIC) models
- Features: Digital, programmable, rechargeable, and Bluetooth-enabled
- Accessories: NoiseProtection Ear Buds, Battery Tester, Brush, Wax Guard, Batteries
- Special Kits: MSIED Kit (Multi-Sensory Educational Development) and TLM Kit (Teaching Learning Material)
Certifications and Manufacturing
- ISO 13485 Certified manufacturing facility
- Central Drugs Standard Control Organization (CDSCO) Approved
- BIS Certified (Bureau of Indian Standards) - Licence No. CM/L-8800111109 for Behind the Ear Hearing Aids
Technology Innovation
- OMNI 2.0: World's 1st Full Stack Remote Hearing Diagnostic system with tele-audiology capabilities
- Patent granted for "Smart Sound Treatment and Diagnosis System and Method Thereof" under The Patents Act, 1970
- Features: Comprehensive testing (Video Otoscopy, Air & Bone Conduction Audiometry, Tympannometry, OAE), portable design, remote operation, rechargeable battery
Management Profile
- Mr. Rohit Misra: Promoter & Managing Director, 30+ years experience, instrumental in setting company vision and growth
- Mr. Ajay kumar Giri: Promoter & Whole-Time Director, oversees daily operations, audiology, and customer service teams
- Mr. Rahul Salesha: Oversees Product Development, Strategic Planning, and Business Growth
- Ms. Monika Misra: Leads Accounts and Finance division
Growth Strategy and Expansion Plans
- Aim to become largest clinic network by 2027
- Advance OMNI platform with tele-audiology and remote hearing capabilities
- Global expansion through USA subsidiary (Earkart Inc.) and planned UK subsidiary
- Exclusive partnership with Arphi Electronics for pan-India distribution
- Expand government procurement channels (GeM, ALIMCO)
- Pursue strategic partnerships and selective acquisitions
Market Context
- Global hearing aid market valued at $8.1B in 2023, projected 6.6% CAGR to reach $12.67B by 2030
- WHO estimates less than 20% have access to hearing aids globally
- India has approximately 7,500 registered audiologists for 1.4 billion population (1 per 1.87 lakh people vs WHO benchmark of 1 per 25,000)
- Around 90 million Indians estimated with hearing loss; treatment penetration below 1%
Recent Participation
- World's largest otolaryngology conference in Indianapolis, USA (October 11-13, 2025)
- AOICON Kolkata 2026 engagement with ENT professionals and audiologists